Business Description
Grand Pharmaceutical Group Ltd
ISIN : BMG210A71198
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.73 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.23 | |||||
Debt-to-EBITDA | 1.34 | |||||
Interest Coverage | 12.98 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.86 | |||||
Beneish M-Score | -2.41 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 33 | |||||
3-Year EBITDA Growth Rate | 35.7 | |||||
3-Year EPS without NRI Growth Rate | 18.3 | |||||
3-Year FCF Growth Rate | 20.3 | |||||
3-Year Book Growth Rate | 17.1 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.64 | |||||
9-Day RSI | 57.93 | |||||
14-Day RSI | 57.25 | |||||
6-1 Month Momentum % | 0.5 | |||||
12-1 Month Momentum % | -21.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.22 | |||||
Quick Ratio | 0.98 | |||||
Cash Ratio | 0.43 | |||||
Days Inventory | 116.54 | |||||
Days Sales Outstanding | 47.73 | |||||
Days Payable | 98.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.46 | |||||
Dividend Payout Ratio | 0.27 | |||||
3-Year Dividend Growth Rate | 8.6 | |||||
Forward Dividend Yield % | 6.42 | |||||
5-Year Yield-on-Cost % | 3.33 | |||||
3-Year Average Share Buyback Ratio | -1.7 | |||||
Shareholder Yield % | -1.21 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.96 | |||||
Operating Margin % | 25.29 | |||||
Net Margin % | 17.85 | |||||
FCF Margin % | 6.97 | |||||
ROE % | 12.89 | |||||
ROA % | 8.38 | |||||
ROIC % | 10.66 | |||||
ROC (Joel Greenblatt) % | 60.75 | |||||
ROCE % | 15.72 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 7.95 | |||||
PE Ratio without NRI | 8.19 | |||||
Shiller PE Ratio | 13.74 | |||||
Price-to-Owner-Earnings | 7.77 | |||||
PEG Ratio | 0.29 | |||||
PS Ratio | 1.51 | |||||
PB Ratio | 0.98 | |||||
Price-to-Tangible-Book | 1.15 | |||||
Price-to-Free-Cash-Flow | 21.49 | |||||
Price-to-Operating-Cash-Flow | 8.75 | |||||
EV-to-EBIT | 5.93 | |||||
EV-to-EBITDA | 5.93 | |||||
EV-to-Revenue | 1.44 | |||||
EV-to-FCF | 20.22 | |||||
Price-to-Projected-FCF | 0.37 | |||||
Price-to-DCF (Earnings Based) | 0.26 | |||||
Price-to-DCF (FCF Based) | 0.89 | |||||
Price-to-Median-PS-Value | 0.53 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.29 | |||||
Price-to-Graham-Number | 0.65 | |||||
Earnings Yield (Greenblatt) % | 16.86 | |||||
FCF Yield % | 4.92 | |||||
Forward Rate of Return (Yacktman) % | 27.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Grand Pharmaceutical Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 10,529.59 | ||
EPS (TTM) (HK$) | 0.536 | ||
Beta | 0.75 | ||
Volatility % | 33.23 | ||
14-Day RSI | 57.25 | ||
14-Day ATR (HK$) | 0.131599 | ||
20-Day SMA (HK$) | 4.0315 | ||
12-1 Month Momentum % | -21.36 | ||
52-Week Range (HK$) | 3.17 - 5.4 | ||
Shares Outstanding (Mil) | 3,501.81 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Grand Pharmaceutical Group Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Grand Pharmaceutical Group Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Grand Pharmaceutical Group Ltd Frequently Asked Questions
What is Grand Pharmaceutical Group Ltd(HKSE:00512)'s stock price today?
When is next earnings date of Grand Pharmaceutical Group Ltd(HKSE:00512)?
Does Grand Pharmaceutical Group Ltd(HKSE:00512) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |